Mycosis fungoides and Sezary syndrome.
Diamandidou
E
E
Department of Bioimmunotherapy, University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA.
Cohen
P R
PR
Kurzrock
R
R
D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002648:Child; D016207:Cytokines / Q000032:analysis; D003937:Diagnosis, Differential; D018450:Disease Progression; D005260:Female; D006680:HLA Antigens / Q000032:analysis; D006564:Herpesviridae / Q000472:pathogenicity; D006566:Herpesviridae Infections / Q000150:complications; D015368:Human T-lymphotropic virus 1 / Q000472:pathogenicity; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D015994:Incidence; D018799:Intercellular Adhesion Molecule-1 / Q000032:analysis; D008297:Male; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000473:pathology / Q000628:therapy; D009363:Neoplasm Proteins / Q000032:analysis; D009367:Neoplasm Staging; D009857:Oncogenes; D011701:PUVA Therapy; D011230:Precancerous Conditions / Q000473:pathology; D011379:Prognosis; D012192:Retroviridae Infections / Q000150:complications; D012751:Sezary Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000473:pathology / Q000628:therapy; D012871:Skin Diseases / Q000175:diagnosis / Q000473:pathology; D012878:Skin Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000473:pathology / Q000628:therapy; D014412:Tumor Virus Infections / Q000150:complications
D016207:Cytokines; D006680:HLA Antigens; D007155:Immunologic Factors; D009363:Neoplasm Proteins; D018799:Intercellular Adhesion Molecule-1